Columbia University scientists have used 'base editing' technology on human embryos for the first time.
Unlike CRISPR, this method changes a single 'letter' of the genetic code without cutting DNA.
The experiment edited three genes: PCSK9, HBG1, and HBG2.
Researchers note the method is not yet ready for clinical use.
Bioethicists warn of potential misuse for genetic enhancement.












